The estimated Net Worth of Christopher Causey is at least $3.94 Milion dollars as of 21 August 2024. Mr. Causey owns over 1,210 units of United Therapeutics Corp stock worth over $1,867,695 and over the last 20 years he sold UTHR stock worth over $1,603,121. In addition, he makes $466,712 as Independent Director at United Therapeutics Corp.
Christopher has made over 160 trades of the United Therapeutics Corp stock since 2004, according to the Form 4 filled with the SEC. Most recently he exercised 1,210 units of UTHR stock worth $160,083 on 21 August 2024.
The largest trade he's ever made was exercising 7,500 units of United Therapeutics Corp stock on 2 November 2022 worth over $1,315,725. On average, Christopher trades about 1,554 units every 38 days since 2004. As of 21 August 2024 he still owns at least 5,395 units of United Therapeutics Corp stock.
You can see the complete history of Mr. Causey stock trades at the bottom of the page.
Christopher Causey serves as Independent Director of the Company. Mr. Causey has served as the Principal of the Causey Consortium, a professional services organization providing business strategy and marketing counsel to the healthcare industry, since 2002. Previously, Mr. Causey served as a senior marketing officer for a variety of healthcare companies. From 2001 to 2002, Mr. Causey served as the Chief Marketing Officer for Definity Health Incorporated. He was also a member of the board of directors of Data Sciences International, Inc., a private company that develops wireless physiological monitoring solutions, from 2008 to 2013. Mr. Causey has served as a United Therapeutics director since 2003.
As the Independent Director of United Therapeutics Corp, the total compensation of Christopher Causey at United Therapeutics Corp is $466,712. There are 11 executives at United Therapeutics Corp getting paid more, with Martine Rothblatt having the highest compensation of $15,627,500.
Christopher Causey is 57, he's been the Independent Director of United Therapeutics Corp since 2003. There are 10 older and 7 younger executives at United Therapeutics Corp. The oldest executive at United Therapeutics Corp is Louis Sullivan, 86, who is the Independent Director.
Christopher's mailing address filed with the SEC is C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING, MD, 20910.
Over the last 20 years, insiders at United Therapeutics Corp have traded over $68,910,395 worth of United Therapeutics Corp stock and bought 229,703 units worth $13,655,671 . The most active insiders traders include Martine A Rothblatt, David Zaccardelli a Roger Jeffs. On average, United Therapeutics Corp executives and independent directors trade stock every 3 days with the average trade being worth of $2,310,818. The most recent stock trade was executed by James Edgemond on 9 September 2024, trading 8,332 units of UTHR stock currently worth $991,341.
united therapeutics corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. we currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! our employees can be found collaborating across the united states, europe and asia. as a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #weareunitherians
United Therapeutics Corp executives and other stock owners filed with the SEC include: